gip and glp-1 agonist Potential Use of GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at? GLP-1 agonists approved for clinical
Description
This design ensures spatial separation of the GLP-1 N-terminus from the albumin moiety, preserving receptor-binding capacity and maintaining full biological activity
Funding This work was supported by Statutory Funds of the Laboratory of Immunoendocrinology, Maj Institute of Pharmacology, Cracow, Poland
(9) Bone resorption is accomplished through the enzymatic activity of osteoclasts
Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, et al
doi: 10.1038/npp.2009.104 162 PytkaK.DziubinaA.MlyniecK.DziedziczakA.ZmudzkaE.FurgalaA.et al
